Document Detail


Lack of yohimbine effect on ambulatory blood pressure recording: a double-blind cross-over trial in parkinsonians with orthostatic hypotension.
MedLine Citation:
PMID:  8294084     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Yohimbine is an alpha 2-adrenergic antagonist which has been proposed for the treatment of orthostatic hypotension (OH). We investigated in a double-blind placebo-controlled crossover trial the effects of yohimbine (2 mg tid) on blood pressure (BP) and heart rate (HR) using ambulatory monitoring of blood pressure (AMBP) in 17 patients (69 +/- 5 years) with Parkinson's disease (PD) suffering from non drug-induced OH. At the end of each sequence of 4 weeks, mean systolic (SBP) and diastolic (DBP) BP and HR (+/- SD), BP variability (coefficient of variation of the mean) and nychtemeral rhythm were calculated for day-time (09:00-19:00 h) and night-time (23:00-06:00 h). OH related to PD was characterized by: i) loss of the nychtemeral rhythm of BP (night/day ratio: 1.18 +/- 0.14) but not of HR (night/day ratio: 0.87 +/- 0.04), ii) high variability of BP during day-time and iii) post-prandial hypotension (12 out of 17 patients). There was no significant difference in AMBP parameters between baseline, yohimbine and placebo periods. This study shows that AMBP is a simple and reproducible method to assess the effects of drugs used in the management of OH on BP parameters (mean values and variability) and that yohimbine is not effective to correct OH of PD. Future studies must investigate other more selective alpha 2-adrenergic antagonists.
Authors:
J M Senard; O Rascol; A Rascol; J L Montastruc
Related Documents :
11551374 - Using out of office blood pressure monitoring in the management of hypertension.
1390514 - Spontaneous subconjunctival haemorrhage--a sign of hypertension?
8809594 - Electrocortical responses to ecologically relevant visual stimuli among professional dr...
9118514 - Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-...
939774 - Suppression of the progress of necrosis after coronary artery ligation in the dog by ph...
3790044 - The concept of "end-systolic" pressure-volume and length-tension relations of the heart...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Fundamental & clinical pharmacology     Volume:  7     ISSN:  0767-3981     ISO Abbreviation:  Fundam Clin Pharmacol     Publication Date:  1993  
Date Detail:
Created Date:  1994-02-25     Completed Date:  1994-02-25     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8710411     Medline TA:  Fundam Clin Pharmacol     Country:  FRANCE    
Other Details:
Languages:  eng     Pagination:  465-70     Citation Subset:  IM; S    
Affiliation:
Laboratoire de Pharmacologie Médicale et Clinique, INSERM U317, Faculté de Médecine, Toulouse, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Ambulatory Care
Blood Pressure / drug effects*
Blood Pressure Determination / methods
Double-Blind Method
Female
Humans
Hypotension, Orthostatic / drug therapy*
Male
Middle Aged
Monitoring, Physiologic / methods
Parkinson Disease, Secondary / drug therapy*
Placebos
Chemical
Reg. No./Substance:
0/Placebos

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dopaminergic modulation of visual sensitivity in man.
Next Document:  Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid tre...